Barclays »

Compass Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $196k 126k 1.56
2023-09-30 $59k 30k 1.95
2023-06-30 $101k 32k 3.16
2023-03-31 $135k 41k 3.28
2022-12-31 $91k 18k 4.97
2022-09-30 $1.0k 374 2.67